Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 12-2023 | 12-2017 | 12-2006 | |
| Operating Expenses | 3,663 | 2,752 | 2,752 | 0 | 0 |
| Operating Income | 0 | 0 | -2,752 | N/A | N/A |
| Interest Expense | 9 | 53 | 53 | 0 | 0 |
| Other Income | 1,021 | -51,106 | -48,354 | 0 | 0 |
| Pre-tax Income | 1,012 | -51,159 | -51,159 | 0 | 0 |
| Net Income Continuous | 1,012 | -51,159 | -51,159 | N/A | N/A |
| Net Income | $1,012 | $-51,159 | $-51,159 | $N/A | $N/A |
| EPS Basic Total Ops | 5.24 | -4,674.25 | -6.14 | N/A | N/A |
| EPS Basic Continuous Ops | 5.24 | -4,692.20 | -6.14 | N/A | N/A |
| EPS Diluted Total Ops | 5.24 | -4,674.25 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 5.24 | -4,692.20 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 5.24 | -4,673.85 | N/A | N/A | N/A |
| EBITDA(a) | $-3,659 | $-2,752 | $-2,752 | $N/A | $N/A |